Home » Topics » BioWorld Science

BioWorld Science
RSS

Imfinzi approved in Japan for the treatment of unresectable stage III NSCLC

July 2, 2018

LEO Pharma initiates phase I study of LEO-138559

July 2, 2018

JCR initiates phase II study of JR-141 as treatment of Hunter syndrome in Brazil

July 2, 2018

EMA committee recommends marketing authorization for Veyvondi

July 2, 2018

IMpassion130 study of Tecentriq plus Abraxane meets primary endpoint

July 2, 2018

Lynparza receives Japanese approval for BRCA-mutated metastatic breast cancer

July 2, 2018

CHMP adopts positive opinion for Yescarta

July 2, 2018

Phase II results presented from pivotal CAPTIVATE trial of ibrutinib plus venetoclax

July 2, 2018

Refixia obtain Japanese approval for the treatment of hemophilia B

July 2, 2018

Kymriah granted positive CHMP opinion for the treatment of two aggressive blood cancers

July 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...